Achieve Life Sciences, Inc. (ACHV) financial statements (2022 and earlier)

Company profile

Business Address 22722 29TH DR. SE
SEATTLE, WA 98021
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:43,02235,85316,70014,6005,28425,50055,200
Cash and cash equivalents43,02235,85316,6649,5155,28415,23334,310
Short-term investments   5,089 10,23020,876
Other undisclosed cash, cash equivalents, and short-term investments  36(4) 3714
Restricted cash and investments    222  
Receivables153 879510125
Prepaid expense  662926393  
Other undisclosed current assets1,4191,122(36)4 9171,973
Total current assets:44,59436,97517,33415,5375,90826,92757,298
Noncurrent Assets
Operating lease, right-of-use asset64146329
Property, plant and equipment1542573559258602
Intangible assets, net (including goodwill)2,6752,8983,1213,3443,566  
Goodwill1,0341,0341,0341,0341,034  
Intangible assets, net (excluding goodwill)1,6411,8642,0872,3102,532  
Restricted cash and investments 50505050272272
Other noncurrent assets 1871871183091337
Other undisclosed noncurrent assets168      
Total noncurrent assets:2,9223,3233,7443,5473,984543911
TOTAL ASSETS:47,51640,29821,07819,0849,89227,47058,209
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1292,3902,2792,0601,1094,7513,251
Accounts payable8413328591442132,1211,343
Accrued liabilities3485843047484382,442641
Employee-related liabilities1,9401,4741,1161,1684581881,267
Debt  20311275752
Deferred revenue and credits  5,040
Other undisclosed current liabilities1,4215453871,1998773,64712,321
Total current liabilities:4,5502,9352,8693,2702,0138,45520,664
Noncurrent Liabilities
Long-term debt and lease obligation14,9247715912 49105
Long-term debt, excluding current maturities14,920      
Capital lease obligations12 49105
Operating lease, liability477159
Other undisclosed noncurrent liabilities(4)(77)     
Total noncurrent liabilities:14,9247715912 49105
Total liabilities:19,4743,0123,0283,2822,0138,50420,769
Stockholders' equity
Stockholders' equity attributable to parent28,04237,28618,05015,8027,87918,96637,440
Common stock79764118122929
Additional paid in capital121,54597,64063,70941,16120,556213,239211,590
Accumulated other comprehensive income444452,6402,632
Accumulated deficit(93,586)(60,434)(45,704)(25,381)(12,694)(196,942)(176,811)
Total stockholders' equity:28,04237,28618,05015,8027,87918,96637,440
TOTAL LIABILITIES AND EQUITY:47,51640,29821,07819,0849,89227,47058,209

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues
(Revenue, Net)
     5,062 
Cost of revenue     (956) 
Gross profit:     4,106 
Operating expenses(33,294)(14,950)(16,528)(12,813)(6,632)(25,298)(36,913)
Operating loss:(33,294)(14,950)(16,528)(12,813)(6,632)(21,192)(36,913)
Nonoperating income (expense)(58)20133126(7,002)1,0631,952
Investment income, nonoperating17691701711,293203119
Other nonoperating expense(75)(49)(37)(45)(35)(13)(64)
Loss from continuing operations before equity method investments, income taxes:(33,352)(14,930)(16,395)(12,687)(13,634)(20,129)(34,961)
Other undisclosed income from continuing operations before income taxes200      
Loss from continuing operations before income taxes:(33,152)(14,930)(16,395)(12,687)(13,634)(20,129)(34,961)
Income tax benefit    3,051  
Loss before gain (loss) on sale of properties:(33,152)(14,930)(16,395)(12,687)(10,583)(20,129)(34,961)
Other undisclosed net income 200     
Net loss:(33,152)(14,730)(16,395)(12,687)(10,583)(20,129)(34,961)
Other undisclosed net income attributable to parent      18,160
Net loss available to common stockholders, diluted:(33,152)(14,730)(16,395)(12,687)(10,583)(20,129)(16,801)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(33,152)(14,730)(16,395)(12,687)(10,583)(20,129)(34,961)
Other comprehensive income (loss)   (1) 810
Comprehensive loss:(33,152)(14,730)(16,395)(12,688)(10,583)(20,121)(34,951)
Other undisclosed comprehensive income, net of tax, attributable to parent   1  18,160
Comprehensive loss, net of tax, attributable to parent:(33,152)(14,730)(16,395)(12,687)(10,583)(20,121)(16,791)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: